Ivosenib 250 mg is a precision-targeted, once-daily oral cancer therapy that contains ivosidenib, a first-in-class inhibitor of mutant IDH1 (isocitrate

Laronib 100 mg Capsule

Molecule : LarotrectinibManufacturer : Everest Pharma

Laronib 25 mg Capsule

Molecule : LarotrectinibManufacturer : Everest Pharma

Lenvaxen 10 mg Capsule

Molecule : LenvatinibManufacturer : Everest Pharma

Lenvaxen 4 mg Capsule

Molecule : LenvatinibManufacturer : Everest Pharma

Lorbrexen 100 mg Tablet

Molecule : LorlatinibManufacturer : Everest Pharma

Magnito 365 mg Tablet

Molecule : MagnesiumManufacturer : Everest Pharma

Mavixen Tablet

Molecule : GlecaprevirManufacturer : Everest Pharma

Mezoxia 160 mg Tablet

Molecule : Megestrol AcetateManufacturer : Everest Pharma

Moboxen 40 mg Capsule

Molecule : MobocertinibManufacturer : Everest Pharma

Nexataf 25 mg Tablet

Molecule : Tenofovir AlafenamideManufacturer : Everest Pharma

Niranib 100 mg Capsule

Molecule : NiraparibManufacturer : Everest Pharma

Olanib 150 mg Tablet

Molecule : OlaparibManufacturer : Everest Pharma

Olanib 50 mg Capsule

Molecule : OlaparibManufacturer : Everest Pharma

Please fill in the details below, and we’ll get back to you as soon as possible